Why the study?
What are the clinical and electrophysiological effects of intravenous quinidine in patients with arrhythmias, including those with bundle-branch block?
What are the clinical and electrophysiological effects of intravenous quinidine in patients with arrhythmias, including those with bundle-branch block?
Intravenous quinidine can be administered to patients with bundle-branch block without significant conduction worsening, though it frequently causes hypotension requiring careful monitoring.
Answers are grounded in this paper and cite their sources.
May warrant hypotension monitoring with IV quinidine; leaves open conduction safety in larger bundle-branch block cohorts.
Quinidine gluconate (total dose 4-4 to 9-1 mg/kg) was infused intravenously over 22 minutes in 20 patients with either frequent premature ventricular contractions or supraventricular arrhythmias, 16 of whom had bundle-branch block. Therapeutic plasma quinidine levels (3 to 7 mg/l) were achieved in 15. Heart rate, atrioventricular nodal, and infranodal conduction times did not change significantly. The QRS duration increased significantly from 128+/-30 to 134+/-29 ms at peak plasma quinidine levels (P less than 0.01). Mild hypotension occurred during infusion in most patients. Two patients had a severe but transient toxic response characterised by hypotension, nausea, vomiting, and diaphoresis. Atrioventricular dissociation with escape His bundle or fascicular rhythm occurred in 1 patient with sinus bradycardia. Bundle-branch block does not contraindicate administration of quinidine. Quinidine gluconate administered intravenously (0-3 to 0-4 mg/kg per min) is frequently associated with hypotenstion and should be used only in an intensive care setting and with careful monitoring of blood pressure.
No takes yet. Share an insight, caveat, or question.
Hirschfeld et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: